
Meliora Therapeutics Private Limited
About Meliora Therapeutics Private Limited
Data last updated:
Meliora Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 21 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC156140.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Ravindra Babu Gogineni and Saichandra Gogineni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹43,986, a decline of 80% compared to the previous year. For the same year it recorded a net loss of ₹7.63 Lakh and EBITDA of -₹5.32 Lakh.
Company details
Contact details
Meliora Therapeutics Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meliora Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Meliora Therapeutics Private Limited, buy the company report.
Financials of Meliora Therapeutics Private Limited
FY 2025 filings availableMeliora Therapeutics Private Limited reported revenue of ₹43,986 (down 80% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 80% in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹5.32 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹7.63 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Meliora Therapeutics Private Limited, buy the company report.
Board of directors of Meliora Therapeutics Private Limited
Meliora Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravindra Babu Gogineni Also directs: Verdant Life Sciences Private Limited | Director | 21 Oct 2021 | 5 Years 0 Months | Current |
| Saichandra Gogineni Also directs: Vedadri Envirotech Foundation | Director | 21 Oct 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Meliora Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meliora Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Meliora Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Meliora Therapeutics Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ravindra Babu Gogineni was appointed as Director on 21 Oct 2021.
Frequently asked questions
Meliora Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 21 October 2021 (5+ years old) and is registered under CIN U24290TG2021PTC156140.
Meliora Therapeutics has 2 current directors:
- Ravindra Babu Gogineni - Director
- Saichandra Gogineni - Director
The latest financial statements of Meliora Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Meliora Therapeutics is U24290TG2021PTC156140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meliora Therapeutics was incorporated on 21 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ravindra Babu Gogineni was appointed as Director on 21 Oct 2021. Saichandra Gogineni was appointed as Director on 21 Oct 2021.
The registered office of Meliora Therapeutics is at H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.
Meliora Therapeutics operates in the chemicals and materials industry, in the industrial chemicals segment.
Meliora Therapeutics can be reached at its registered office: H No. 5 – 315 S R C Naik Nagar Ida Jeedimetla Qutubullapur, Hyderabad, Telangana, India – 500055.
Meliora Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

